PE20040578A1 - Derivados de 1-[(indol-3-il)carbonil]piperazina - Google Patents

Derivados de 1-[(indol-3-il)carbonil]piperazina

Info

Publication number
PE20040578A1
PE20040578A1 PE2003000614A PE2003000614A PE20040578A1 PE 20040578 A1 PE20040578 A1 PE 20040578A1 PE 2003000614 A PE2003000614 A PE 2003000614A PE 2003000614 A PE2003000614 A PE 2003000614A PE 20040578 A1 PE20040578 A1 PE 20040578A1
Authority
PE
Peru
Prior art keywords
indol
carbonyl
alkyloxy
halogen
alkyl
Prior art date
Application number
PE2003000614A
Other languages
English (en)
Inventor
Phillip Martin Cowley
James Cairns
Julia Adam-Worrall
Mark York
Jason Tierney
Wilson Caulfield
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of PE20040578A1 publication Critical patent/PE20040578A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Nutrition Science (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA I DONDE R TIENE 1-4 SUSTITUYENTES COMO H, ALQUILO C1-C4, ALQUILOXI C1-C4, HALOGENO, ENTRE OTROS; R1 ES CICLOALQUILO C5-C8, CICLOALQUENILO C5-C8; R2 ES H, METILO, ETILO; R3, R3'. R4, R4', R5, R5' Y R6' SON CADA UNO H, ALQUILO C1-C4 OPCIONALMENTE SUSTITUIDO CON HALOGENO, OH, ALQUILOXI C1-C4, ENTRE OTROS; R6 ES H, ALQUILO C1-C4 OPCIONALMENTE SUSTITUIDO CON ALQUILOXI C1-C4, HALOGENO U OH, ENTRE OTROS; R7 ES H, ALQUILO C1-C4, CICLOALQUILO C3-C5, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: 1-{[1-(CICLOHEXILMETIL)-7-METOXI-1H-INDOL-3-IL]CARBONIL}-3,5-DIMETIL-4-ETILPIPERAZINA; 1-{[1-(CICLOHEXILMETIL)-7-METOXI-1H-INDOL-3-IL]CARBONIL}-3,4,5-TRIMETILPIPERAZINA; ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA UTIL EN EL TRATAMIENTO DEL DOLOR
PE2003000614A 2002-06-21 2003-06-18 Derivados de 1-[(indol-3-il)carbonil]piperazina PE20040578A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02077505 2002-06-21

Publications (1)

Publication Number Publication Date
PE20040578A1 true PE20040578A1 (es) 2004-09-15

Family

ID=29797228

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2003000614A PE20040578A1 (es) 2002-06-21 2003-06-18 Derivados de 1-[(indol-3-il)carbonil]piperazina

Country Status (33)

Country Link
US (1) US7304064B2 (es)
EP (1) EP1549637B1 (es)
JP (1) JP4408804B2 (es)
KR (1) KR20050009755A (es)
CN (1) CN1298716C (es)
AR (1) AR040274A1 (es)
AT (1) ATE361290T1 (es)
AU (1) AU2003250245B2 (es)
BR (1) BR0311960A (es)
CA (1) CA2490141C (es)
CO (1) CO5680419A2 (es)
CY (1) CY1107677T1 (es)
DE (1) DE60313640T2 (es)
DK (1) DK1549637T3 (es)
EC (1) ECSP045503A (es)
ES (1) ES2285183T3 (es)
HK (1) HK1076630A1 (es)
HR (1) HRP20041186A2 (es)
IL (1) IL165572A0 (es)
IS (1) IS2443B (es)
MX (1) MXPA04012856A (es)
NO (1) NO20045351L (es)
NZ (1) NZ537143A (es)
PE (1) PE20040578A1 (es)
PL (1) PL375152A1 (es)
PT (1) PT1549637E (es)
RS (1) RS111104A (es)
RU (1) RU2318821C2 (es)
SI (1) SI1549637T1 (es)
TW (1) TW200402417A (es)
UA (1) UA78317C2 (es)
WO (1) WO2004000832A1 (es)
ZA (1) ZA200410057B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI242015B (en) 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
JP4667867B2 (ja) 2002-08-02 2011-04-13 メルク・シャープ・エンド・ドーム・コーポレイション 置換フロ［２，３−ｂ］ピリジン誘導体
DE10253426B4 (de) * 2002-11-15 2005-09-22 Elbion Ag Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phosphodiesterase 4 und Verfahren zu deren Herstellung
US7772227B2 (en) 2003-12-17 2010-08-10 N.V. Organon Tricyclic 1-[(indol-3-yl)carbonyl]piperazine derivatives as cannabinoid CB1 receptor agonists
TWI330635B (en) * 2004-03-05 2010-09-21 Organon Nv (indol-3-yl)-heterocycle derivatives
AU2006268680B2 (en) * 2005-07-11 2012-11-22 Msd Oss B.V. Synergistic combination for the treatment of pain (cannabioid receptor agonist and opiod receptor agonist)
WO2007014851A2 (en) * 2005-07-29 2007-02-08 F. Hoffmann-La Roche Ag Indol-3-yl-carbonyl-piperidin and piperazin derivatives
TW200745096A (en) * 2005-08-23 2007-12-16 Organon Nv Indole derivatives
US7763732B2 (en) 2005-08-24 2010-07-27 N.V. Organon Indole derivatives
AU2006295130A1 (en) * 2005-09-23 2007-04-05 Janssen Pharmaceutica, N.V. Tetrahydro-indazolyl cannabinoid modulators
TW200848417A (en) 2007-02-22 2008-12-16 Organon Nv Indole derivatives
RU2387642C2 (ru) 2007-10-31 2010-04-27 Общество С Ограниченной Ответственностью "Бинатех" Производные 5-замещенных индол-3-карбоновой кислоты, обладающие противовирусной активностью, способ их получения и применение
GB201106817D0 (en) * 2011-04-21 2011-06-01 Astex Therapeutics Ltd New compound
RS62301B1 (sr) 2013-12-20 2021-09-30 Astex Therapeutics Ltd Biciklična heterociklična jedinjenja i njihove upotrebe u terapiji
TW201938164A (zh) * 2018-01-08 2019-10-01 瑞士商赫孚孟拉羅股份公司 新穎雜環化合物
CN108752342A (zh) * 2018-08-17 2018-11-06 西安瑞联新材料股份有限公司 1-H-吡啶并[1,2-a]-6-氢吡嗪-1,4-二酮的制备方法
CN111100063B (zh) * 2018-10-25 2022-05-17 南京药石科技股份有限公司 一种合成2-氟甲基取代的吡咯烷、哌啶以及哌嗪衍生物的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998006715A1 (en) 1996-08-09 1998-02-19 Smithkline Beecham Corporation Novel piperazine containing compounds
EP1243268A4 (en) 1999-12-14 2003-05-21 Nippon Shinyaku Co Ltd MEDICINAL COMPOSITION
AU2001234958A1 (en) 2000-02-11 2001-08-20 Bristol-Myers Squibb Company Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases

Also Published As

Publication number Publication date
HRP20041186A2 (en) 2005-06-30
CO5680419A2 (es) 2006-09-29
CN1668611A (zh) 2005-09-14
AR040274A1 (es) 2005-03-23
ES2285183T3 (es) 2007-11-16
PT1549637E (pt) 2007-05-31
HK1076630A1 (en) 2006-01-20
NZ537143A (en) 2005-05-27
IS7590A (is) 2004-12-09
DE60313640D1 (de) 2007-06-14
ZA200410057B (en) 2005-10-20
ATE361290T1 (de) 2007-05-15
MXPA04012856A (es) 2005-03-31
DK1549637T3 (da) 2007-07-16
CY1107677T1 (el) 2013-04-18
AU2003250245B2 (en) 2008-07-03
CA2490141A1 (en) 2003-12-31
RS111104A (en) 2007-02-05
DE60313640T2 (de) 2007-12-27
US20050250760A1 (en) 2005-11-10
BR0311960A (pt) 2005-03-22
TW200402417A (en) 2004-02-16
CN1298716C (zh) 2007-02-07
SI1549637T1 (sl) 2007-10-31
IS2443B (is) 2008-11-15
PL375152A1 (en) 2005-11-28
EP1549637B1 (en) 2007-05-02
NO20045351L (no) 2005-01-20
KR20050009755A (ko) 2005-01-25
IL165572A0 (en) 2006-01-15
US7304064B2 (en) 2007-12-04
WO2004000832A1 (en) 2003-12-31
ECSP045503A (es) 2005-03-10
UA78317C2 (en) 2007-03-15
RU2005101349A (ru) 2005-06-27
JP4408804B2 (ja) 2010-02-03
JP2005533801A (ja) 2005-11-10
EP1549637A1 (en) 2005-07-06
RU2318821C2 (ru) 2008-03-10
AU2003250245A1 (en) 2004-01-06
CA2490141C (en) 2011-01-25

Similar Documents

Publication Publication Date Title
PE20040578A1 (es) Derivados de 1-[(indol-3-il)carbonil]piperazina
RU2214400C2 (ru) Производные 1-[(1-замещенного-4-пиперидинил)метил]-4-пиперидина, способы их получения, фармацевтическая композиция на их основе и промежуточные вещества
PE20090816A1 (es) Derivados de pirrolopirimidinona como agentes ligandos de los receptores p2x3
PE20040687A1 (es) Quinolinas sustituidas como antagonistas del receptor ccr5
EA200300919A1 (ru) N-замещенные неарильные гетероциклические антагонисты nmda/nr2b
RU2000129161A (ru) Производное 1-[(1-замещенного-4-пиперидинил)метил]-4-пиперидина, способ его получения, фармацевтическая композиция, содержащая указанное соединение, и промежуточный продукт
NO20056007L (no) Dobbel NK1/NK3 antagonister for behandling av schizofreni
PE20040720A1 (es) Derivados de benzodioxol
PE20001303A1 (es) Derivados de la 4-aroilpiperidina como antagonistas del receptor ccr-3
PE20071177A1 (es) Derivados de 3,5-piridina como inhibidores de renina
CO5640136A2 (es) Derivados de hexahidropiridoisoquinolinas inhibidores de dpp-iv y composiciones farmaceuticas que los contienen
PE20050874A1 (es) Compuestos de bencimidazolona que tienen actividad agonista del receptor 5-ht4
PE20090422A1 (es) Derivados de piperidina, piperazina o tetrahidropiridilo como antagonistas de trpv1
BR0312882A (pt) Derivados de pleuromutilina como antimicrobianos
PE20080345A1 (es) Derivados de piperazina como agonistas del receptor de gpr38
ATE495187T1 (de) Dalda-analoge und ihre verwendung
EA200602176A1 (ru) Производные тетрагидроизохинолилсульфонамидов, их получение и применение в терапии
CO5611143A2 (es) Profarmacos de fosfatos de fluorooxindoles
AP1816A (en) 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists.
PE20090712A1 (es) Moduladores de la gamma secretasa
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
ATE175661T1 (de) Benzamid-derivate als vasopressin-antagonisten
GB0314967D0 (en) Piperazine derivatives
TW200420545A (en) 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
HUP0102931A2 (hu) Új N-(triazolil-metil)-piperazin-származékok mint neurokininreceptor-antagonisták

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed